Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06790602 |
| Title | Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma (SWITCH) |
| Acronym | SWITCH |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | University of California, San Diego |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California, San Diego | RECRUITING | La Jolla | California | 92093 | United States | Details |